Continuous and bimonthly publication
ISSN (on-line): 1806-3756

Licença Creative Commons
2643
Views
Back to summary
Open Access Peer-Reviewed
Artigo Original

Benzbromarone as adjuvant therapy for cystic fibrosis lung disease: a pilot clinical trial

Benzbromarone as adjuvant therapy for cystic fibrosis lung disease: a pilot clinical trial

Frederico Friedrich1, Lucas Montiel Petry1, Laura de Castro e Garcia1, Marina Puerari Pieta1, Amanda da Silva Meneses1, Luana Braga Bittencourt1, Luiza Fernandes Xavier1, Marcos Otávio Brum Antunes1, Lucas Kich Grun1,2, Magali Lumertz1, Karl Kunzelmann3, Leonardo Araujo Pinto1

DOI: https://dx.doi.org/10.36416/1806-3756/e20230292

1. Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul – PUCRS – Porto Alegre (RS) Brasil.
2. Laboratório de Imunobiologia, Pontifícia Universidade Católica do Rio Grande do Sul – PUCRS – Porto Alegre (RS) Brasil.
3. Physiological Institute, University of Regensburg, Regensburg, Germany.
Submitted: 6 September 2023.
Accepted: 21 December 2023.
Study carried out at the Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul – PUCRS –
Porto Alegre (RS) Brasil.

Correspondence to:
Frederico Friedrich. Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Avenida Ipiranga, 6690, CEP 90610-000, Porto Alegre, RS, Brasil.
Fax: 55 51 3320-3312. Tel.: 55 51 3320-3000. E-mail: frederico.friedrich@pucrs.br
Financial support: This study received financial support from the Brazilian Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Office for the Advancement of Higher Education; Funding Code 001).

Indexes

Development by:

© All rights reserved 2025 - Jornal Brasileiro de Pneumologia